Clinical Trial Results: Urinary Incontinence

Product Name: Alpha 1A/1L agonist
Date of Report: 8/1/2005
Phase: II
Randomized, double-blind, placebo-controlled, study to evaluate the safety of a partial alpha_1A/1L-adrenoceptor agonist, RO 115-1240, in women with stress urinary incontinence or mixed urinary incontinence.

Product Name: Alpha 1A/1L agonist
Date of Report: 1/1/2006
Phase: II
Randomized, double-blind, placebo-controlled, dose-finding study to evaluate the effects of a partial alpha_1A/1L-adrenoceptor agonist, RO 115-1240 in women with stress incontinence or mixed urinary incontinence.

Product Name: Alpha 1A/1L agonist
Date of Report: 1/1/2006
Phase: II
Open-label Extension for treatment of incontinent patients who have completed an Ro115-1240 study.